Literature DB >> 15777021

Generation of bile pigments by haem oxygenase: a refined cellular strategy in response to stressful insults.

Roberta Foresti1, Colin J Green, Roberto Motterlini.   

Abstract

The family of haem oxygenase enzymes is unique in nature for its role in haem degradation. Haem is cleaved at the alpha-meso position by haem oxygenase with the support of electrons donated by cytochrome P450 reductase, the first products of this reaction being CO, iron and biliverdin. Biliverdin is then converted to bilirubin by biliverdin reductase. If haem is viewed as a substrate for an anabolic pathway, it becomes evident that haem oxygenases do not break down haem for elimination from the body, but rather use haem to generate crucial molecules that can modulate cellular functions. The facts that biliverdin and bilirubin are potent antioxidants and that CO is both a vasoactive and signalling molecule sustain this idea. The existence of a constitutive haem oxygenase (HO-2), mainly present in the vasculature and nervous system, and an inducible haem oxygenase (HO-1), which is highly expressed during stress conditions in all tissues, also suggests that cells have evolved a fine control of this enzymic pathway to ultimately regulate haem consumption and to ensure production of CO, biliverdin/bilirubin and iron during physiological and pathophysiological situations. This review will focus primarily on the biological actions of biliverdin and bilirubin derived from the haem oxygenase/biliverdin reductase systems and their potential roles in counteracting oxidative and nitrosative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15777021     DOI: 10.1042/bss0710177

Source DB:  PubMed          Journal:  Biochem Soc Symp        ISSN: 0067-8694


  22 in total

1.  Activation of biliverdin-IXalpha reductase by inorganic phosphate and related anions.

Authors:  Edward Franklin; Seamus Browne; Jerrard Hayes; Coilin Boland; Aisling Dunne; Gordon Elliot; Timothy J Mantle
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

Review 2.  Heme oxygenase-1 and gut ischemia/reperfusion injury: A short review.

Authors:  Yu-Feng Liao; Wei Zhu; Dong-Pei Li; Xiao Zhu
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

3.  Positive inotropic effects of carbon monoxide-releasing molecules (CO-RMs) in the isolated perfused rat heart.

Authors:  M D Musameh; B J Fuller; B E Mann; C J Green; R Motterlini
Journal:  Br J Pharmacol       Date:  2006-10-23       Impact factor: 8.739

4.  Biliverdin amides reveal roles for propionate side chains in bilin reductase recognition and in holophytochrome assembly and photoconversion.

Authors:  Lixia Shang; Nathan C Rockwell; Shelley S Martin; J Clark Lagarias
Journal:  Biochemistry       Date:  2010-07-27       Impact factor: 3.162

Review 5.  Metalloporphyrins in the management of neonatal hyperbilirubinemia.

Authors:  David K Stevenson; Ronald J Wong
Journal:  Semin Fetal Neonatal Med       Date:  2009-12-16       Impact factor: 3.926

Review 6.  Use of carbon monoxide as a therapeutic agent: promises and challenges.

Authors:  Roberta Foresti; Mohamed G Bani-Hani; Roberto Motterlini
Journal:  Intensive Care Med       Date:  2008-02-20       Impact factor: 17.440

7.  Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression.

Authors:  Marcienne M Wright; Francisco J Schopfer; Paul R S Baker; Vijay Vidyasagar; Pam Powell; Phil Chumley; Karen E Iles; Bruce A Freeman; Anupam Agarwal
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

Review 8.  Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-17       Impact factor: 6.914

9.  Exacerbated corneal inflammation and neovascularization in the HO-2 null mice is ameliorated by biliverdin.

Authors:  Lars Bellner; Marco Vitto; Kiran A Patil; Michael W Dunn; Raymond Regan; Michal Laniado-Schwartzman
Journal:  Exp Eye Res       Date:  2008-06-17       Impact factor: 3.467

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.